| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1314216 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of LATS2 mRNA | CTD | PMID:22079256 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of LATS2 mRNA | CTD | PMID:21570461 |
| 2-methoxyethanol | increases expression | ISO | RGD:1305906 | 6480464 | methyl cellosolve results in increased expression of LATS2 mRNA | CTD | PMID:21061450 |
| 5-aza-2'-deoxycytidine | affects methylation | ISO | RGD:1314216 | 6480464 | decitabine affects the methylation of LATS2 promoter | CTD | PMID:17049657 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1314216 | 6480464 | [decitabine affects the methylation of LATS2 promoter] which affects the expression of LATS2 mRNA | CTD | PMID:17049657 PMID:17049657 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1314216 | 6480464 | [decitabine affects the methylation of LATS2 promoter] which affects the expression of LATS2 mRNA | CTD | PMID:17049657 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of LATS2 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to LATS2 promoter] | CTD | PMID:19654925 |
| bisphenol A | affects expression | ISO | RGD:1314216 | 6480464 | bisphenol A affects the expression of LATS2 mRNA | CTD | PMID:20170705 |
| C60 fullerene | decreases expression | ISO | RGD:1305906 | 6480464 | fullerene C60 results in decreased expression of LATS2 mRNA | CTD | PMID:19167457 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LATS2 gene | CTD | PMID:20938992 |
| copper atom | multiple interactions | ISO | RGD:1314216 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of LATS2 mRNA | CTD | PMID:20971185 |
| copper atom | decreases expression | ISO | RGD:1314216 | 6480464 | Copper results in decreased expression of LATS2 protein | CTD | PMID:16246896 |
| copper(0) | multiple interactions | ISO | RGD:1314216 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of LATS2 mRNA | CTD | PMID:20971185 |
| copper(0) | decreases expression | ISO | RGD:1314216 | 6480464 | Copper results in decreased expression of LATS2 protein | CTD | PMID:16246896 |
| copper(2+) sulfate | increases expression | ISO | RGD:1314216 | 6480464 | Copper Sulfate results in increased expression of LATS2 mRNA | CTD | PMID:19549813 |
| crocidolite asbestos | increases expression | ISO | RGD:1314216 | 6480464 | Asbestos, Crocidolite results in increased expression of LATS2 mRNA | CTD | PMID:18687144 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of LATS2 mRNA | CTD | PMID:19770486 |
| diarsenic trioxide | increases expression | ISO | RGD:1314216 | 6480464 | arsenic trioxide results in increased expression of LATS2 mRNA | CTD | PMID:20458559 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of LATS2 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of LATS2 mRNA | CTD | PMID:17361019 PMID:21266533 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LATS2 gene | CTD | PMID:20938992 |
| hydrogen peroxide | affects expression | ISO | RGD:1314216 | 6480464 | Hydrogen Peroxide affects the expression of LATS2 mRNA | CTD | PMID:20044591 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LATS2 gene | CTD | PMID:20938992 |
| menadione | affects expression | ISO | RGD:1314216 | 6480464 | Vitamin K 3 affects the expression of LATS2 mRNA | CTD | PMID:20044591 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of LATS2 mRNA | CTD | PMID:17562736 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of LATS2 mRNA | CTD | PMID:23091169 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of LATS2 mRNA | CTD | PMID:17484886 |
| thalidomide | increases expression | ISO | RGD:1314216 | 6480464 | Thalidomide analog results in increased expression of LATS2 mRNA | CTD | PMID:20525221 |
| zinc atom | multiple interactions | ISO | RGD:1314216 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of LATS2 mRNA | CTD | PMID:18593933 |
| zinc(0) | multiple interactions | ISO | RGD:1314216 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of LATS2 mRNA | CTD | PMID:18593933 |